PAY WITH VISA, MASTERCARD, INTERAC

AOD-9604 Canada: A Research Guide to the hGH Fragment Peptide

For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition.

AOD-9604 is a synthetic peptide that appears in the published literature as a modified fragment of human growth hormone. Canadian laboratories searching for “AOD-9604 Canada” generally want practical answers: what the molecule is, how it is described in the research record, how to handle it, and what documentation a supplier should provide. This guide covers each from a laboratory perspective.

What Is AOD-9604?

AOD-9604 corresponds to residues 177 to 191 of the C-terminal region of human growth hormone, with an additional tyrosine at the N-terminus. The result is a 16-residue peptide with an intramolecular disulfide bridge between two cysteine residues and a molecular weight of roughly 1,815 g/mol. The tyrosine addition was introduced in the original design work to support stability and to allow straightforward radiolabelling and detection in analytical workflows.

Because the sequence contains a disulfide bond, it is a good illustration of why identity confirmation matters. A reduced or scrambled disulfide variant can look similar by purity percentage alone yet behave differently in an assay, so mass data and method details are worth reading closely.

AOD-9604 in the Research Literature

Published work, largely preclinical and in vitro, has examined AOD-9604 as a tool for studying the C-terminal domain of growth hormone separately from the intact protein. Reported areas of investigation include lipid-handling pathways in cultured adipocyte models, cartilage-related cell culture work, and comparisons against the full-length hormone to understand which structural regions drive which signalling readouts. These studies are exploratory, model-specific and should not be generalised. Nothing in this article should be read as evidence of any effect in humans.

Typical laboratory uses include:

  • Structure-activity studies comparing hormone fragments with the full-length protein
  • Peptide stability and degradation studies in defined buffers or biological matrices
  • Analytical method development for cyclic, disulfide-containing peptides
  • Cell-based signalling and metabolic assays described in the published literature

Handling and Storage for Laboratory Use

Research-grade peptides are normally supplied as lyophilised powder. Good handling protects both the material and the integrity of your data:

  • Store sealed vials cold and dry. Unopened lyophilised peptide is generally kept at -20 °C, away from light and moisture.
  • Equilibrate before opening. Let the vial reach room temperature to limit condensation on the powder.
  • Protect the disulfide bridge. Avoid reducing agents and extreme pH unless the experimental design calls for them.
  • Choose solvents deliberately. Sterile or bacteriostatic water is the usual choice. Our reconstitution guide for researchers walks through technique.
  • Limit freeze-thaw cycles. Aliquot working solutions and record preparation dates so results stay reproducible.

For PPE, sharps and waste, see the peptide handling safety guide.

Quality Documentation to Expect

A single purity percentage does not describe a peptide. When evaluating any AOD-9604 supplier, researchers should expect:

  • A batch-specific Certificate of Analysis (COA) whose lot number matches the vial received
  • HPLC purity data, with the chromatogram or method details available on request
  • Mass spectrometry identity confirmation showing the observed mass agrees with the expected value for the oxidised, disulfide-bridged form
  • Clear research-use-only labelling and a matching safety data sheet

To go deeper, read our articles on verifying batch-specific COAs, HPLC peptide purity and testing for counterfeit peptides.

Regulatory and Sourcing Considerations in Canada

AOD-9604 is not an approved therapeutic product in Canada, and research peptides must be bought, labelled and used strictly as laboratory reagents by qualified researchers. A research label does not shield a shipment from scrutiny at the border, a point we cover in peptide customs in Canada. Imported parcels can be delayed or held, which disrupts study timelines and cold-chain integrity. Many labs therefore prefer a domestic supplier, as explained in our piece on importing peptides into Canada.

PeptiLab supplies research-grade peptides from within Canada with batch documentation for each lot. Laboratories working on metabolic-pathway peptides can review the MOTS-C research product page for a comparable specification and COA format, and the full catalogue is listed on our research peptides Canada page. Researchers who need AOD-9604 specifically should contact us to ask about availability before planning a study.

Key Takeaways for Researchers

AOD-9604 is a modified growth hormone fragment used as a laboratory tool for studying structure-activity relationships, peptide stability and signalling pathways described in preclinical work. Its disulfide bridge makes identity confirmation especially important, so insist on batch-matched HPLC and mass spectrometry data. Reliable results come from verified material, cold and dry storage, consistent reconstitution technique and a supplier whose paperwork matches the vial in your hand.

All products referenced are sold strictly for in vitro laboratory research and analytical use by qualified researchers. They are not drugs, foods, cosmetics or supplements, and are not for human or animal consumption. Nothing in this article constitutes medical advice, dosing guidance or a claim of therapeutic benefit.

For research use only. Not for human consumption, therapeutic, diagnostic, or veterinary use.